black box warning

A black box warning is the strongest safety alert a drug regulator can put on a medicine's label — literally a warning set inside a bold black border so it cannot be missed. It says, in effect: this drug can do serious harm, so read this before you prescribe.

The term comes from the United States Food and Drug Administration, which reserves the boxed warning for risks that may be serious, life-threatening, or fatal. The warning does not ban the drug; rather it forces the most dangerous information to the top of the label and demands that prescribers weigh it carefully, sometimes with required risk-management steps such as monitoring, patient counselling, or restricted distribution.

Boxed warnings are added when accumulating evidence — often from post-marketing surveillance, not the original trials — reveals a danger important enough to demand special attention. Examples include the increased suicidality risk flagged on certain antidepressants in young people, the tendon-rupture and other risks on fluoroquinolone antibiotics, and bleeding risks on anticoagulants.

An honest perspective: a black box warning signals seriousness, not that a drug should never be used. Many boxed-warning drugs remain first-line therapies because their benefit outweighs the flagged risk in the right patient. The warning is a prompt for informed judgement, not an automatic prohibition — and similar 'strongest warning' mechanisms exist under other regulators worldwide.